查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1977784

经导管心臟瓣膜全球市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Transcatheter Heart Valve Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 110 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

经导管心臟瓣膜市场预计将从 2025 年的 69.2 亿美元成长到 2034 年的 265 亿美元，2026 年至 2034 年的复合年增长率为 16.09%。

由于瓣膜性心臟病发病率不断上升以及人口老化加剧，全球经导管心臟瓣膜市场正在快速扩张。与开胸手术相比，微创经导管手术恢復时间更短，手术风险更低，从而增加了患者的选择。

主要驱动因素包括瓣膜设计和影像系统进步带来的手术效果改善。早期诊断意识提升的提高和医疗保险覆盖范围的扩大也促进了瓣膜植入率的上升。越来越多的临床证据支持瓣膜的长期安全性和有效性，进一步推动了市场成长。

未来，新一代瓣膜系统的持续创新以及在更年轻患者群体中的应用拓展有望推动进一步成长。新兴市场医疗基础设施的扩建也将开闢新的成长途径。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球经导管心臟瓣膜市场：依应用划分

  • 市场分析、洞察与预测
  • 主动脉瓣
  • 肺动脉瓣
  • 二尖瓣

第五章：全球经导管心臟瓣膜市场：依技术划分

  • 市场分析、洞察与预测
  • 球囊扩张型经导管瓣膜
  • 自膨式经导管瓣膜

第六章 全球经导管心臟瓣膜市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Boston Scientific Corporation
    • Bracco Group
    • Braile Biomedica
    • Direct Flow Medical
    • Edwards Lifesciences
    • JenaValve
    • Abbott（St. Jude Medical）
    • Symetis
    • ValveXchange Inc
简介目录
Product Code: VMR112113300

The Transcatheter Heart Valve Market size is expected to reach USD 26.50 Billion in 2034 from USD 6.92 Billion (2025) growing at a CAGR of 16.09% during 2026-2034.

The global transcatheter heart valve market is expanding rapidly due to the increasing prevalence of valvular heart diseases and the growing elderly population. Minimally invasive transcatheter procedures offer reduced recovery time and lower surgical risks compared to open-heart surgery, driving patient preference.

Key drivers include technological advancements in valve design and imaging systems, improving procedural outcomes. Rising awareness about early diagnosis and expanding healthcare coverage are also contributing to higher adoption rates. Increasing clinical evidence supporting long-term safety and effectiveness further strengthens market growth.

In the future, ongoing innovation in next-generation valve systems and expanding indications for younger patient groups may fuel further expansion. Growing healthcare infrastructure in emerging markets will also create new growth avenues.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Transcatheter Aortic Valve
  • Transcatheter Pulmonary Valve
  • Transcatheter Mitral Valve

By Technology

  • Balloon Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve

COMPANIES PROFILED

  • Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, Abbott St Jude Medical, Symetis, ValveXchange Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL TRANSCATHETER HEART VALVE MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Transcatheter Aortic Valve Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Transcatheter Pulmonary Valve Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Transcatheter Mitral Valve Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TRANSCATHETER HEART VALVE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Balloon Expanded Transcatheter Valve Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Self-Expanded Transcatheter Valve Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TRANSCATHETER HEART VALVE MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Application
    • 6.2.2 By Technology
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Application
    • 6.3.2 By Technology
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Application
    • 6.4.2 By Technology
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Application
    • 6.5.2 By Technology
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Application
    • 6.6.2 By Technology
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL TRANSCATHETER HEART VALVE INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Boston Scientific Corporation
    • 8.2.2 Bracco Group
    • 8.2.3 Braile Biomedica
    • 8.2.4 Direct Flow Medical
    • 8.2.5 Edwards Lifesciences
    • 8.2.6 JenaValve
    • 8.2.7 Abbott (St. Jude Medical)
    • 8.2.8 Symetis
    • 8.2.9 ValveXchange Inc